Miraculins Inc., a medical diagnostic company focused on developing and commercializing diagnostic tests for unmet clinical needs, announced that it has completed the acquisition from PreMD Inc. of all assets relating to the PREVU* Skin Cholesterol Test.
Read MoreCepheid announced that its Xpert MTB/RIF test was the subject of a study published in the latest edition of the New England Journal of Medicine (NEJM), “Rapid Molecular Detection of Tuberculosis and Rifampin Resistance.”
Read More
Inside this issue of CLP magazine, you’ll find our third annual respiratory virus supplement, which I hope you find useful as you prepare for the upcoming flu season. We are all breathing a bit easier now than we were at this time last y
Read More
Experts discuss trends in the field of serology testing.
Read More
MRSA is declining but still deadly, while other HIAs continue to grow in prevalence.
Read More